← Eichor · All briefs

NCT06293820 — Allergic Conjunctivitis trial site landscape

Public-registry site landscape for NCT06293820, a Allergic Conjunctivitis study sponsored by Telios Pharma, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.

TrialNCT06293820 (registry record)
SponsorTelios Pharma, Inc.
Condition(s)Allergic Conjunctivitis
PhasePHASE2
Listed sites1
Site countriesUnited States

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT06293820 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.